News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nanostart-holding MagForce Nanotechnologies Announces Capital Increase from Authorized Capital



2/1/2012 6:07:22 AM

FRANKFURT, Germany & BERLIN--(BUSINESS WIRE)--The Management Board of Nanostart (OTCQX:NASRY) - holding MagForce AG (XETRA:MF6), a leading medical technology company focusing on nanomedicine in oncology, and its Supervisory Board yesterday approved an increase in the company’s share capital from EUR 4,127,041.00 up to EUR 4,952,449.00 through the partial utilization of its existing authorized capital of up to EUR 825,408.00 newly registered common shares with no par value common with a nominal value of EUR 1.00 per share against cash contributions.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES